December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Schrodinger, Inc. - Common Stock (NQ:SDGR)

25.93 -1.36 (-4.97%)
Delayed Quote Updated: 2:06 PM EDT, Oct 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Schrodinger, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
Largest Clinical-Stage BioTech Drug Stocks Declined 6% ↗
Of the 10 clinical-stage AI-focused and psychedelic compound-based small cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, only 1 advanced this week. On average they... 
Via Talk Markets
News headline image
AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th ↗
The global 
Via Talk Markets
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week ↗
The global 
Via Talk Markets
News headline image
Critical Insights From Schrodinger Analyst Ratings: What You Need To Know ↗
 
Via Benzinga
News headline image
The 7 AI Categories Were Down 4%, On Average, This Week; Up 1% In May ↗
The 7 AI categories we track dropped, down 4.3% this week, and are now only up 1.3% for the month of May. 
Via Talk Markets
Topics Artificial Intelligence
News headline image
Schrödinger to Present at Jefferies Global Healthcare Conference
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs ↗
AI continues to impact pharma stocks to buy in a major way, with these shares particularly well positioned as things heat up. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
What's the Difference Between Biotech Stocks and TechBio Stocks? ↗
A few enterprising businesses are marketing themselves differently. 
Via The Motley Fool
News headline image
Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week ↗
Via Talk Markets
News headline image
The 7 AI Categories Declined, On Average, The First Week Of May ↗
Via Talk Markets
Topics Artificial Intelligence
News headline image
Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May ↗
We look at the performance of 10 clinical-stage AI-powered and psychedelic compound-based small cap drug discovery companies during the first week of May and YTD. 
Via Talk Markets
News headline image
Etsy Reports Downbeat Earnings, Joins Fastly, DoorDash And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
SDGR Stock Earnings: Schrodinger Misses EPS, Misses Revenue for Q1 2024 ↗
SDGR stock results show that Schrodinger missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Schrödinger Reports First Quarter 2024 Financial Results
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
The 10 Stocks In The Clinical-Stage BioTech Drug Stocks Index Are Down 4% YTD ↗
The pharmaceutical industry is embracing AI to streamline drug discovery and researching the use of psychedelic compound-based ingredients for the treatment of, as yet, untreatable diseases. 
Via Talk Markets
Topics Artificial Intelligence
News headline image
Schrödinger to Announce First Quarter 2024 Financial Results on May 1
From Schrödinger
Via Business Wire
News headline image
5 Healthcare Stocks to Buy for 2024 ↗
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Invest Like Bill Gates With These 3 AI Stocks to Buy ↗
Bill Gates is undoubtedly interested in AI stocks to buy. Here are three of his foundation’s current holdings. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Shhh! 7 Small-Cap Stocks That Can Double by 2025 ↗
Small-cap stocks have been hot and these shares discussed here are likely to heat up and double over the next year. 
Via InvestorPlace
News headline image
Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
Billionaire Bill Gates Has 35% of His Portfolio Invested in These 2 Artificial Intelligence (AI) Stocks: Are They No-Brainer Buys? ↗
AI is a key growth driver for both of these stocks owned by the Gates Foundation Trust. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD ↗
Grand View Research says the global 
Via Talk Markets
News headline image
The Hot List: 3 AI Stocks Worth Buying on Weakness ↗
Firms using AI directly can be great picks for long-term investors, such as these three AI stocks to buy on weakness. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.